GR1007770B - Φαρμακευτικο σκευασμα περιεχον ρεπαγλινιδη και μεθοδος για την παρασκευη αυτου - Google Patents

Φαρμακευτικο σκευασμα περιεχον ρεπαγλινιδη και μεθοδος για την παρασκευη αυτου

Info

Publication number
GR1007770B
GR1007770B GR20110100470A GR20110100470A GR1007770B GR 1007770 B GR1007770 B GR 1007770B GR 20110100470 A GR20110100470 A GR 20110100470A GR 20110100470 A GR20110100470 A GR 20110100470A GR 1007770 B GR1007770 B GR 1007770B
Authority
GR
Greece
Prior art keywords
preparation
repaglinide
pharmaceutical
containing solution
drastic
Prior art date
Application number
GR20110100470A
Other languages
English (en)
Inventor
Ευαγγελος Ανδρεα Καραβας
Ευθυμιος Χρηστου Κουτρης
Ιωαννα Χρηστου Κουτρη
Βικυ Χρηστου Σαμαρα
Αναστασια Λεωνιδα Καλασκανη
Original Assignee
Φαρματεν Αβεε,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Φαρματεν Αβεε, filed Critical Φαρματεν Αβεε,
Priority to GR20110100470A priority Critical patent/GR1007770B/el
Publication of GR1007770B publication Critical patent/GR1007770B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σταθερή φαρμακευτική σύνθεση περιέχουσα Ρεπαγλινίδη και δύο τουλάχιστον μη υδατοδιαλυτά αραιωτικά μέσα καθώς και τη μέθοδο παρασκευής αυτής της σύνθεσης, στην οποία η δραστική ουσία έχει μέγεθος σωματιδίου Dgo περίπου 50 μm για να διασφαλιστεί ο επιθυμητός ρυθμός διάλυσης.
GR20110100470A 2011-08-04 2011-08-04 Φαρμακευτικο σκευασμα περιεχον ρεπαγλινιδη και μεθοδος για την παρασκευη αυτου GR1007770B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20110100470A GR1007770B (el) 2011-08-04 2011-08-04 Φαρμακευτικο σκευασμα περιεχον ρεπαγλινιδη και μεθοδος για την παρασκευη αυτου

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20110100470A GR1007770B (el) 2011-08-04 2011-08-04 Φαρμακευτικο σκευασμα περιεχον ρεπαγλινιδη και μεθοδος για την παρασκευη αυτου

Publications (1)

Publication Number Publication Date
GR1007770B true GR1007770B (el) 2012-11-22

Family

ID=47562155

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20110100470A GR1007770B (el) 2011-08-04 2011-08-04 Φαρμακευτικο σκευασμα περιεχον ρεπαγλινιδη και μεθοδος για την παρασκευη αυτου

Country Status (1)

Country Link
GR (1) GR1007770B (el)

Similar Documents

Publication Publication Date Title
MX2013007057A (es) Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos.
PH12015502615B1 (en) Chemical compounds
LT2807159T (lt) Nauji indolizino junginiai, jų gamybos būdai ir juos turinčios farmacinės kompozicijos, skirtos vėžio gydymui
TN2015000278A1 (en) Autotaxin inhibitors
PH12013501136A1 (en) Lysophosphatidic acid receptor antagonists and uses thereof
MY173259A (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
GB201106743D0 (en) Novel compounds
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
IL233200A0 (en) The history of alpha-boronic acid, its preparation and pharmaceutical preparations containing it
SG10201804817TA (en) Delayed release compositions of linaclotide
MX348823B (es) Formulaciones estables de linaclotida.
ZA201301463B (en) Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same
PH12014500219A1 (en) Polyacrylate-based active compound-comprising particles
IL231383A0 (en) History of imidazole amines, their preparation and pharmaceutical preparations containing them
MX2013009531A (es) Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
EA201301264A1 (ru) Способ получения неорганического материала в виде частиц
IL227024A (en) The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
HUP1300647A2 (hu) Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
EP2875814A4 (en) LIQUID COMPOSITION CONTAINING TAXANE ACTIVE INGREDIENT, MANUFACTURING METHOD THEREOF, AND LIQUID MEDICINAL PREPARATION
MX2013012773A (es) Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas.
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
EA201190282A1 (ru) Фармацевтическая композиция, содержащая тамсулозин

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20130122

ML Lapse due to non-payment of fees

Effective date: 20160303